Literature DB >> 30117504

Tracking mitochondrial dynamics during apoptosis with phosphorescent fluorinated iridium(iii) complexes.

Chen Zhang1, Kangqiang Qiu2, Chaofeng Liu1, Huaiyi Huang1, Thomas W Rees1, Liangnian Ji1, Qianling Zhang3, Hui Chao2.   

Abstract

Mitochondria are the control centers of apoptosis. To study mitochondrial dynamics during apoptosis, four phosphorescent fluorinated iridium(iii) complexes (Ir1-Ir4) were designed and synthesized. The complexes' emission maxima, phosphorescent quantum yields, and phosphorescent lifetimes are tuned by the degree of fluorination of the ligand. The complexes exhibit excellent photostability and low (photo)cytotoxicity in HeLa cells. As the complexes are cationic and lipophilic, they localize in mitochondria and enter cells through an energy-independent pathway. In comparison with commercially available mitochondrial trackers (e.g., MTR), Ir1-Ir4 exhibit high specificity to mitochondria even in fixed cells. Due to these outstanding properties, the complexes were successfully used to track mitochondrial dynamics during apoptosis.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30117504     DOI: 10.1039/c8dt02918k

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  3 in total

1.  Ir(III)-Based Agents for Monitoring the Cytochrome P450 3A4 Active Site Occupancy.

Authors:  Madeline Denison; Sean J Steinke; Aliza Majeed; Claudia Turro; Thomas A Kocarek; Irina F Sevrioukova; Jeremy J Kodanko
Journal:  Inorg Chem       Date:  2022-08-22       Impact factor: 5.436

Review 2.  Metal Peptide Conjugates in Cell and Tissue Imaging and Biosensing.

Authors:  Karmel S Gkika; David Cullinane; Tia E Keyes
Journal:  Top Curr Chem (Cham)       Date:  2022-06-15

3.  Mitochondria-targeted half-sandwich iridium(iii)-Cp*-arylimidazophenanthroline complexes as antiproliferative and bioimaging agents against triple negative breast cancer cells MDA-MB-468.

Authors:  Ashaparna Mondal; Shanooja Shanavas; Utsav Sen; Utpal Das; Nilmadhab Roy; Bipasha Bose; Priyankar Paira
Journal:  RSC Adv       Date:  2022-04-19       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.